Full text is available at the source.
International journal of radiation oncology, biology, physics···
Blocking PLK1 May Make Breast Cancer Cells More Sensitive to Radiation by Reducing Their Self-Protection Process
Updated
Abstract
PLK1 inhibition enhanced the radiosensitivity of breast cancer cells in vivo (n = 4, P = .002).
- PLK1 inhibition significantly suppressed breast cancer cell proliferation.
- Pharmacologic inhibition of PLK1 increased radiosensitivity in breast cancer cells.
- Inhibition of PLK1 reduced radiation-induced reactive oxygen species and autophagy.
- A positive correlation was observed between PLK1 and autophagy marker LC3 in human breast cancer samples (n = 102, R = 0.486, P = .005).
Simplified
PURPOSE: Polo-like kinase 1 (PLK1) is a protein kinase that is overexpressed in breast cancer and may represent an attractive target for breast cancer treatment. However, few studies have investigated the relationship between PLK1 and radiosensitivity in breast cancer. Here, we attempted to explore whether PLK1 inhibition could sensitize breast cancer cells to radiation.
METHODS AND MATERIALS: Breast cancer cells were treated with PLK1 small interference RNA or the PLK1-inhibitor, GSK461364. Cell proliferation was assessed using a colony formation assay. Cell cycle analyses were performed by flow cytometry. DNA damage, autophagy, and reactive oxygen species induced by ionizing radiation were detected by immunofluorescence, Western blot, and flow cytometry, respectively. Microtubule-associated protein 1 light chain 3 alpha (LC3) puncta were detected using an immunofluorescence assay. A clonogenic survival assay was used to determine the effect of PLK1 inhibition on cell radiosensitivity. A xenograft mouse model of breast cancer cells was used to investigate the potential synergistic effects of PLK1 inhibition and irradiation in vivo. Finally, the expression of PLK1 and LC3 in the breast cancer tissues was evaluated by immunohistochemistry.
RESULTS: PLK1 inhibition significantly suppressed the proliferation and increased the radiosensitivity of breast cancer cells. Pharmacologic inhibition of PLK1 by the selective inhibitor, GSK461364, enhanced the radiosensitivity of breast cancer cells in vivo (n = 4, P = .002). Mechanistically, PLK1 inhibition led to the downregulation of radiation-induced reactive oxygen species and autophagy, thereby increasing the radiosensitivity of breast cancer cells. Additionally, we detected a positive correlation between the expression of PLK1 and LC3 in human breast cancer samples (n = 102, R = 0.486, P = .005).
CONCLUSIONS: Our findings indicate that PLK1 inhibition enhances the radiosensitivity of breast cancer cells in a manner associated with the suppression of radiation-induced autophagy. The inhibition of PLK1 represents a promising strategy for radiosensitizing breast cancer.
Related papers
Mar '18
Blocking PLK1 makes breast cancer cells more sensitive to radiation but works poorly alone or with other chemotherapy drugs
top 50% journal
cited by 6 papers
research support, non-u.s. gov't
Oct '15
Blocking PLK1 improves radiation therapy by stopping cancer cells during cell division
top 20% journal
cited by 16 papers
research support, non-u.s. gov't
Nov '18
Impact of blocking PLK1 on stomach cancer cells resistant to cisplatin
cited by 21 papers
research support, non-u.s. gov't
Mar '12
Blocking PLK1 slows growth and increases radiation sensitivity in medulloblastoma cells
top 20% journal
cited by 69 papers
research support, n.i.h., extramural
Dec '16
The GSK461364 drug blocking PLK1 shows strong anti-cancer effects in early neuroblastoma tests
top 30% journal
cited by 41 papers
journal article
Jan '18
Chloroquine may make bladder cancer cells more sensitive to radiation by blocking cell recycling and triggering cell death
top 30% journal
cited by 80 papers
journal article
Sep '11
Blocking Polo-like kinase 1 may stop metastatic breast cancer cells from growing in the brain
top 10% journal
cited by 37 papers
research support, n.i.h., intramural
Apr '13
Stress in cell protein factories makes human esophageal cancer cells more sensitive to radiation
cited by 55 papers
research support, non-u.s. gov't
Dec '14
Role of PLK1 in hormone-independent growth of estrogen receptor-positive breast cancer
top 2% journal
cited by 55 papers
research support, n.i.h., extramural
Mar '16
Increasing radiation sensitivity in esophageal cancer by blocking polo-like kinase 1
top 30% journal
cited by 8 papers
research support, non-u.s. gov't